Endometrial Cancer Market

Endometrial Cancer Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

198

Base Year:

2023

Jun - 2024

Format:

Report Code:

VMR-2522

Segments Covered

By Type of Cancer Endometrial Carcinoma, Uterine Sarcomas, Others
By Type of Therapy Immunotherapy, Radiation Therapy, Chemotherapy, Others
By Diagnosis Method Biopsy, CT Scan Hysteroscopy, Pelvic Ultrasound, Other Diagnosis Methods
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 28.2 Billion
Revenue 2032:	USD 46.86 Billion
Revenue CAGR (2024 - 2032):	5.8%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Endometrial Cancer Market - Segment Analysis
1. Overview
2. Global Endometrial Cancer Market, 2016 - 2028 (USD Million)
3. Global Endometrial Cancer Market - by Type of Cancer
  1. By Endometrial Carcinoma
  2. By Uterine Sarcomas
  3. By Others
4. Global Endometrial Cancer Market - by Type of Therapy
  1. By Immunotherapy
  2. By Radiation Therapy
  3. By Chemotherapy
  4. By Others
5. Global Endometrial Cancer Market - by Diagnosis Method
  1. By Biopsy
  2. By CT Scan Hysteroscopy
  3. By Pelvic Ultrasound
  4. By Other Diagnosis Methods
6. Global Endometrial Cancer Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Endometrial Cancer Market - Segment Analysis
1. Overview
2. North America Endometrial Cancer Market, 2016 - 2028 (USD Million)
3. North America Endometrial Cancer Market, by Type of Cancer
  1. By Endometrial Carcinoma
  2. By Uterine Sarcomas
  3. By Others
4. North America Endometrial Cancer Market, by Type of Therapy
  1. By Immunotherapy
  2. By Radiation Therapy
  3. By Chemotherapy
  4. By Others
5. North America Endometrial Cancer Market, by Diagnosis Method
  1. By Biopsy
  2. By CT Scan Hysteroscopy
  3. By Pelvic Ultrasound
  4. By Other Diagnosis Methods
6. North America Endometrial Cancer Market, by Country
  1. U.S.
    1. U.S. Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. U.S. Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. U.S. Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  2. Canada
    1. Canada Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Canada Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Canada Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  3. Mexico
    1. Mexico Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Mexico Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Mexico Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
Europe Endometrial Cancer Market - Segment Analysis
1. Overview
2. Europe Endometrial Cancer Market, 2016 - 2028 (USD Million)
3. Europe Endometrial Cancer Market, by Type of Cancer
  1. By Endometrial Carcinoma
  2. By Uterine Sarcomas
  3. By Others
4. Europe Endometrial Cancer Market, by Type of Therapy
  1. By Immunotherapy
  2. By Radiation Therapy
  3. By Chemotherapy
  4. By Others
5. Europe Endometrial Cancer Market, by Diagnosis Method
  1. By Biopsy
  2. By CT Scan Hysteroscopy
  3. By Pelvic Ultrasound
  4. By Other Diagnosis Methods
6. Europe Endometrial Cancer Market, by Country
  1. Germany
    1. Germany Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Germany Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Germany Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  2. UK
    1. UK Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. UK Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. UK Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  3. France
    1. France Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. France Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. France Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  4. Spain
    1. Spain Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Spain Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Spain Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  5. Italy
    1. Italy Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Italy Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Italy Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  6. BENELUX
    1. BENELUX Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. BENELUX Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. BENELUX Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  7. Rest of Europe
    1. Rest Of Europe Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Rest Of Europe Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Rest Of Europe Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
Asia Pacific Endometrial Cancer Market - Segment Analysis
1. Overview
2. Asia Pacific Endometrial Cancer Market, 2016 - 2028 (USD Million)
3. Asia Pacific Endometrial Cancer Market, by Type of Cancer
  1. By Endometrial Carcinoma
  2. By Uterine Sarcomas
  3. By Others
4. Asia Pacific Endometrial Cancer Market, by Type of Therapy
  1. By Immunotherapy
  2. By Radiation Therapy
  3. By Chemotherapy
  4. By Others
5. Asia Pacific Endometrial Cancer Market, by Diagnosis Method
  1. By Biopsy
  2. By CT Scan Hysteroscopy
  3. By Pelvic Ultrasound
  4. By Other Diagnosis Methods
6. Asia Pacific Endometrial Cancer Market, by Country
  1. China
    1. China Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. China Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. China Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  2. Japan
    1. Japan Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Japan Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Japan Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  3. India
    1. India Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. India Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. India Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  4. South Korea
    1. South Korea Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. South Korea Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. South Korea Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  5. South East Asia
    1. South East Asia Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. South East Asia Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. South East Asia Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Rest of Asia Pacific Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Rest of Asia Pacific Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
Latin America Endometrial Cancer Market - Segment Analysis
1. Overview
2. Latin America Endometrial Cancer Market, 2016 - 2028 (USD Million)
3. Latin America Endometrial Cancer Market, by Type of Cancer
  1. By Endometrial Carcinoma
  2. By Uterine Sarcomas
  3. By Others
4. Latin America Endometrial Cancer Market, by Type of Therapy
  1. By Immunotherapy
  2. By Radiation Therapy
  3. By Chemotherapy
  4. By Others
5. Latin America Endometrial Cancer Market, by Diagnosis Method
  1. By Biopsy
  2. By CT Scan Hysteroscopy
  3. By Pelvic Ultrasound
  4. By Other Diagnosis Methods
6. Latin America Endometrial Cancer Market, by Country
  1. Brazil
    1. Brazil Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Brazil Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Brazil Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  2. Argentina
    1. Argentina Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Argentina Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Argentina Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  3. Rest of Latin America
    1. Rest of Latin America Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Rest of Latin America Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Rest of Latin America Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
Middle East & Africa Endometrial Cancer Market - Segment Analysis
1. Overview
2. Middle East & Africa Endometrial Cancer Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Endometrial Cancer Market, by Type of Cancer
  1. By Endometrial Carcinoma
  2. By Uterine Sarcomas
  3. By Others
4. Middle East & Africa Endometrial Cancer Market, by Type of Therapy
  1. By Immunotherapy
  2. By Radiation Therapy
  3. By Chemotherapy
  4. By Others
5. Middle East & Africa Endometrial Cancer Market, by Diagnosis Method
  1. By Biopsy
  2. By CT Scan Hysteroscopy
  3. By Pelvic Ultrasound
  4. By Other Diagnosis Methods
6. Middle East & Africa Endometrial Cancer Market, by Country
  1. GCC Countries
    1. GCC Countries Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. GCC Countries Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. GCC Countries Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  2. South Africa
    1. South Africa Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. South Africa Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. South Africa Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Endometrial Cancer Market, By Type of Cancer
      1. By Endometrial Carcinoma
      2. By Uterine Sarcomas
      3. By Others
    2. Rest of Middle East & Africa Endometrial Cancer Market, By Type of Therapy
      1. By Immunotherapy
      2. By Radiation Therapy
      3. By Chemotherapy
      4. By Others
    3. Rest of Middle East & Africa Endometrial Cancer Market, By Diagnosis Method
      1. By Biopsy
      2. By CT Scan Hysteroscopy
      3. By Pelvic Ultrasound
      4. By Other Diagnosis Methods
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Pfizer Inc.
2. GlaxoSmithKline PLC
3. Novartis AG
4. Merck & Co. Inc.
5. AstraZeneca PLC
6. Roche Holding AG
7. Johnson & Johnson
8. Takeda Pharmaceutical Company Limited
9. Bayer AG
10. Amgen Inc.
11. Eli Lilly and Company
12. AbbVie Inc.
13. Sanofi
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Endometrial Cancer in terms of revenue?

The global Endometrial Cancer valued at USD 28.2 Billion in 2023 and is expected to reach USD 46.86 Billion in 2032 growing at a CAGR of 5.8%.

Which are the prominent players in the market?

The prominent players in the market are Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co. Inc., AstraZeneca PLC, Roche Holding AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Bayer AG, Amgen Inc., Eli Lilly and Company, AbbVie Inc., Sanofi.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 5.8% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Endometrial Cancer include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Endometrial Cancer in 2023.

Endometrial Cancer Market

Endometrial Cancer Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Endometrial Cancer in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Endometrial Cancer Market

Endometrial Cancer Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Endometrial Cancer in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Endometrial Cancer Market

Vantage Point Interactive Dashboard